| Date Filed | Type | Description |
| 03/23/2023 |
4
| Nicaise Claude (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 6,857 options to buy
@ $1.62, valued at
$11.1k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 03/08/2023 |
4
| Nicaise Claude (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 1,523 shares
@ $0
Granted 3,257 options to buy
@ $155.99, valued at
$508.1k
|
|
| 09/22/2022 |
4
| Nicaise Claude (Director) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/17/2021 |
3
| Nicaise Claude (Director) has filed a Form 3 on Gain Therapeutics, Inc. |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2019 |
4
| Nicaise Claude (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 1,633 shares
@ $0
Granted 3,213 options to buy
@ $145.48, valued at
$467.4k
|
|
| 03/07/2018 |
4
| Nicaise Claude (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 3,418 shares
@ $0
Granted 4,820 options to buy
@ $71.45, valued at
$344.4k
|
|
| 03/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |